Recce (RCE.AX) traded down -2.9 % during a 24 hours period ending at 11:08 PM Central Europe on Monday 26th. One Recce stock can currently be bought for about AUD 0.32 on popular exchanges. Current supply of Recce stocks is 305.8 mn. Recce has a current market capitalization of AUD 102.4 mn and approximately AUD 42.4 k worth of Recce was traded on exchanges in the last 24 hours. Since last month end, Recce has traded 1.52 % up. Simple moving average of last 200 days is at AUD 0.45. The highest price of past 52 weeks was recorded at AUD 0.73 on 01/15/2026. 52 weeks low was at AUD 0.26 on 10/13/2026.
Here is how related stocks have performed in the past 24 hours:
Grange (GRR.AX) traded flat 0 % and now trades at AUD 0.11. Grange has a market capitalisation of AUD 121.5 mn.
Comet Ridge (COI.AX) traded up 4.41 % and now trades at AUD 0.07. Current market capitalisation for Comet Ridge is AUD 119.2 mn.
Encounter (ENR.AX) traded down -8.7 % and now trades at AUD 0.22. Current market capitalisation for Encounter is AUD 117.6 mn.
Maronan Metals (MMA.AX) traded down -3.21 % and now trades at AUD 0.38. Current market capitalisation for Maronan Metals is AUD 118.6 mn.
Dimerix (DXB.AX) traded down -4.88 % and now trades at AUD 0.2. Current market capitalisation for Dimerix is AUD 117.1 mn.
About Recce
Recce Pharmaceuticals Ltd is a pre-clinical-stage pharmaceutical company based in Bentley, Australia. The company produces antibiotics for human use to tackle the crisis of superbugs. Recce Pharmaceuticals specializes in developing synthetic antibiotics to combat the threat to human health posed by antibiotic-resistant bacteria. The company serves customers in Australia. You can find more information about Recce Pharmaceuticals on their website at www.recce.com.au or through trading on the ASX All Markets.
